MRI for lung cancer radiotherapy

• Research type

  Research Study

• Full title

  Using lung ventilation imaging to optimise lung cancer radiotherapy plans

• IRAS ID

  330496

• Contact name

  Rachel A Pearson

• Contact email

  rachel.pearson1@nhs.net

• Sponsor organisation

  The Newcastle upon Tyne Hospitals NHS Foundation Trust

• Duration of Study in the UK

  0 years, 8 months, 13 days

• Research summary

  Radiotherapy treatment of lung cancer aims to destroy tumour
  and prevent recurrence, whilst limiting radiation exposure to non-tumour regions. Many lung
  cancer patients have other lung disease that result in heterogeneous function, and lung function
  can worsen in some after radiotherapy as the treatment damages the few remaining lung regions
  with good function. We have developed 3D MRI scan measurements of lung function, we will test
  their ability to report on lung functional heterogeneity in lung cancer patients and test the ability
  to use this functional information to produce better radiotherapy treatment strategies that limit
  radiation impact on post-treatment lung function.

• REC name

  London - City & East Research Ethics Committee

• REC reference

  23/PR/1087

• Date of REC Opinion

  6 Oct 2023

• REC opinion

  Favourable Opinion